128 related articles for article (PubMed ID: 3299882)
1. Extracranial carotid arterial disease in patients with familial hypercholesterolemia and coronary artery disease treated with colestipol and nicotinic acid.
Kuo PT; Toole JF; Schaaf JA; Jones A; Wilson AC; Kostis JB; Moreyra AE
Stroke; 1987; 18(4):716-21. PubMed ID: 3299882
[TBL] [Abstract][Full Text] [Related]
2. Familial type II hyperlipoproteinemia with coronary heart disease: effect of diet-colestipol-nicotinic acid treatment.
Kuo PT; Kostis JB; Moreyra AE; Hayes JA
Chest; 1981 Mar; 79(3):286-91. PubMed ID: 7471860
[TBL] [Abstract][Full Text] [Related]
3. Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis.
Glueck CJ
Ann Intern Med; 1982 Apr; 96(4):475-82. PubMed ID: 7039445
[TBL] [Abstract][Full Text] [Related]
4. Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease.
Kuo PT; Wilson AC; Kostis JB; Moreyra AE
Am J Cardiol; 1986 Jun; 57(16):43H-48H. PubMed ID: 3524177
[TBL] [Abstract][Full Text] [Related]
5. [Results of 6 months, therapy of familial hypercholesterolemia (hyperlipoproteinemia type II) with colestipol].
Kuŝić M; Gavrilović M; Mihajloviĉ M; Boŝković B
Srp Arh Celok Lek; 1980 Sep; 108(9):875-81. PubMed ID: 7302695
[No Abstract] [Full Text] [Related]
6. [The long-term effects of colestipol hydrochloride on serum and lipoprotein lipids in patients with heterozygous familial hypercholesterolemia (author's transl)].
Wakasugi T; Sakai T; Watanabe A; Tatami R; Ueda K; Ueda R; Kametani T; Haba T; Koizumi J; Miyamoto S; Mabuchi H; Takeda R; Sakai Y; Yoshimura A; Takegoshi T; Ohta M; Ono S; Ohka T; Takeshita H
Nihon Ronen Igakkai Zasshi; 1981 Nov; 18(6):432-40. PubMed ID: 7339082
[No Abstract] [Full Text] [Related]
7. Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up.
Ojala JP; Helve E; Karjalainen K; Tarkkanen A; Tikkanen MJ
Atherosclerosis; 1990 May; 82(1-2):85-95. PubMed ID: 2360923
[TBL] [Abstract][Full Text] [Related]
8. "Low dose" colestipol in children, adolescents and young adults with familial hypercholesterolemia.
Schlierf G; Mrozik K; Heuck CC; Middelhoff G; Oster P; Riesen W; Schellenberg B
Atherosclerosis; 1982 Jan; 41(1):133-8. PubMed ID: 7073790
[TBL] [Abstract][Full Text] [Related]
9. The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia.
Groot PH; Dijkhuis-Stoffelsma R; Grose WF; Ambagtsheer JJ; Fernandes J
Acta Paediatr Scand; 1983 Jan; 72(1):81-5. PubMed ID: 6407278
[TBL] [Abstract][Full Text] [Related]
10. Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia.
Illingworth DR
Ann Intern Med; 1984 Nov; 101(5):598-604. PubMed ID: 6567462
[TBL] [Abstract][Full Text] [Related]
11. Effects of hypolipidemic therapy on cholesterol homeostasis in freshly isolated mononuclear cells from patients with heterozygous familial hypercholesterolemia.
Sundberg EE; Illingworth DR
Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7631-5. PubMed ID: 6584876
[TBL] [Abstract][Full Text] [Related]
12. Colestipol-niacin therapy and coronary atherosclerosis.
JAMA; 1987 Nov; 258(19):2694-6. PubMed ID: 3669238
[No Abstract] [Full Text] [Related]
13. Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound.
Blankenhorn DH; Selzer RH; Crawford DW; Barth JD; Liu CR; Liu CH; Mack WJ; Alaupovic P
Circulation; 1993 Jul; 88(1):20-8. PubMed ID: 8319334
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.
Blankenhorn DH; Nessim SA; Johnson RL; Sanmarco ME; Azen SP; Cashin-Hemphill L
JAMA; 1987 Jun; 257(23):3233-40. PubMed ID: 3295315
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of familial hypercholesterolemia - hyperlipoproteinemia type II with anion exchange resins].
Kusić M; Gavrilović M; Mihajlović M; Bosković B
Vojnosanit Pregl; 1981; 38(1):23-7. PubMed ID: 7245659
[No Abstract] [Full Text] [Related]
16. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.
Brown G; Albers JJ; Fisher LD; Schaefer SM; Lin JT; Kaplan C; Zhao XQ; Bisson BD; Fitzpatrick VF; Dodge HT
N Engl J Med; 1990 Nov; 323(19):1289-98. PubMed ID: 2215615
[TBL] [Abstract][Full Text] [Related]
17. Primary hypercholesterolemia: effect of treatment on serum lipids, lipoprotein fractions, cholesterol absorption, sterol balance, and platelet aggregation.
Briones ER; Steiger D; Palumbo PJ; Kottke BA
Mayo Clin Proc; 1984 Apr; 59(4):251-7. PubMed ID: 6708603
[TBL] [Abstract][Full Text] [Related]
18. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
Hunninghake DB; Probstfield JL; Crow LO; Isaacson SO
Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197
[TBL] [Abstract][Full Text] [Related]
19. Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia.
Malloy MJ; Kane JP; Kunitake ST; Tun P
Ann Intern Med; 1987 Nov; 107(5):616-23. PubMed ID: 3662275
[TBL] [Abstract][Full Text] [Related]
20. Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography.
Mack WJ; LaBree L; Liu C; Selzer RH; Hodis HN
Atherosclerosis; 2000 Jun; 150(2):371-9. PubMed ID: 10856529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
